High occurrence of giardiasis in children living on a 'landless farm workers' settlement in Araras, São Paulo, Brazil.

Enteric parasitosis remains an important public health problem in many areas around the world including in Brazil, and it is frequently associated with poverty and lack of sanitation facilities. Research carried out over the course of a year revealed that 96.6% (28/29) of children randomly selected from a 'landless farm workers' settlement in Araras, São Paulo, aged 4 - 15 years, presented Giardia intestinalis cysts. After referral to the neighborhood Health Office, all the children received tinidazole, given as a single dose of 50 mg/kg and 12 months later, new fecal samples were collected and analyzed. Despite the low adherence to the study, a high percentage (64.3% - 9/14) of the children remained positive for the parasite. This study showed a high positivity of giardiasis in child residents of the settlement, even after treatment; adults were not sensitized to the study and did not collected and/or deliver children fecal samples. The precarious living conditions are consistent with a high susceptibility to parasitic diseases, suggesting that the treatment of the infected individuals without identifying and eradicating the means of contamination is simply a palliative measure.
AuthorsOswaldo Aparecido de Lima Junior, Juliana Kaiser, Rosana Catisti
JournalRevista do Instituto de Medicina Tropical de São Paulo (Rev Inst Med Trop Sao Paulo) Vol. 55 Issue 3 ( 2013) ISSN: 1678-9946 [Electronic] Brazil
PMID23740012 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiparasitic Agents
  • Tinidazole
  • Adolescent
  • Antiparasitic Agents (therapeutic use)
  • Brazil (epidemiology)
  • Child
  • Child, Preschool
  • Feces (parasitology)
  • Female
  • Giardia lamblia (isolation & purification)
  • Giardiasis (diagnosis, drug therapy, epidemiology)
  • Humans
  • Incidence
  • Male
  • Recurrence
  • Rural Population
  • Socioeconomic Factors
  • Tinidazole (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: